IN8BIO, Inc.
NASDAQ:INAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
US |
|
Cameco Corp
TSX:CCO
|
CA |
|
M
|
Mitsubishi Chemical Holdings Corp
XBER:M3C
|
JP |
|
Nautilus Biotechnology Inc
NASDAQ:NAUT
|
US |
|
Perpetua Resources Corp
TSX:PPTA
|
US |
|
Nostra Terra Oil and Gas Company PLC
LSE:NTOG
|
UK |
|
G
|
Gemfields Group Ltd
JSE:GML
|
GG |
|
Garrett Motion Inc
NASDAQ:GTX
|
CH |
|
Q
|
Qantas Airways Ltd
OTC:QABSY
|
AU |
|
Aker BP ASA
F:ARC
|
NO |
|
Bradespar SA
F:FXMA
|
BR |
|
C
|
Conduent Inc
SWB:4C0
|
US |
|
Bakrie & Brothers Tbk PT
F:LFU2
|
ID |
|
Secure Energy Services Inc
TSX:SES
|
CA |
|
N
|
Nissin Foods Holdings Co Ltd
XMUN:NF2
|
JP |
|
Nextedia SA
F:9KA
|
FR |
|
McCormick & Company Inc
F:MCX0
|
US |
|
A
|
Aker BP ASA
SWB:ARC
|
NO |
|
H
|
HTC Corp
OTC:HTCKF
|
TW |
|
Avolta AG
SIX:AVOL
|
CH |
Wall St Price Targets
INAB Price Targets Summary
IN8BIO, Inc.
According to Wall Street analysts, the average 1-year price target for INAB is 6.38 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INAB's stock price target?
Price Target
6.38
USD
According to Wall Street analysts, the average 1-year price target for INAB is 6.38 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.